{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ciclesonide+HFA", "query": { "intervention": "Ciclesonide HFA" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T02:34:39.976Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00458835", "title": "Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Covis Pharma S.à.r.l.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 30, "start_date": "2007-04", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2023-02-09", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00458835" }, { "nct_id": "NCT00790023", "title": "Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "80 mcg Ciclesonide", "type": "DRUG" }, { "name": "160 mcg Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 707, "start_date": "2008-11", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 4, "location_summary": "Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 1 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Kerrville", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00790023" }, { "nct_id": "NCT01033825", "title": "Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA Nasal Aerosol 320 mcg", "type": "DRUG" }, { "name": "Ciclesonide HFA Nasal Aerosol 160 mcg", "type": "DRUG" }, { "name": "HFA Nasal Aerosol placebo", "type": "DRUG" }, { "name": "Ciclesonide Aqueous Nasal Spray 200 mcg", "type": "DRUG" }, { "name": "AQ Nasal Spray Placebo", "type": "DRUG" }, { "name": "Placebo plus Dexamethasone HFA", "type": "DRUG" }, { "name": "Placebo AQ plus Dexamethasone 6 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 310, "start_date": "2010-01", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-07-19", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 6, "location_summary": "Stockbridge, Georgia • North Dartmouth, Massachusetts • Minneappolis, Minnesota + 3 more", "locations": [ { "city": "Stockbridge", "state": "Georgia" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01033825" }, { "nct_id": "NCT00807053", "title": "Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rhinitis, Allergic, Seasonal" ], "interventions": [ { "name": "Ciclesonide HFA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 480, "start_date": "2007-04", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 31, "location_summary": "Mission Viejo, California • Orange, California • San Diego, California + 28 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00807053" }, { "nct_id": "NCT06272370", "title": "Individualizing Treatment for Asthma in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Bronchial Diseases", "Respiratory Tract Infections", "Lung Diseases, Obstructive", "Lung Diseases", "Respiratory Hypersensitivity", "Immune System Diseases" ], "interventions": [ { "name": "Asthma Symptom Monitoring online tools", "type": "OTHER" }, { "name": "Inhaled Steroids", "type": "DRUG" }, { "name": "Azithromycin Pill", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "DARTNet Institute", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 103, "start_date": "2024-02-01", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2025-04-20", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06272370" }, { "nct_id": "NCT01010971", "title": "Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA 160 μg", "type": "DRUG" }, { "name": "Ciclesonide HFA 80 μg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 671, "start_date": "2009-12", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 7, "location_summary": "Austin, Texas • New Braunfels, Texas • San Antonio, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01010971" }, { "nct_id": "NCT00659048", "title": "Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2004-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659048" }, { "nct_id": "NCT01287364", "title": "Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide hydrofluoroalkane (HFA) nasal aerosol", "type": "DRUG" }, { "name": "mometasone nasal inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 185, "start_date": "2011-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 6, "location_summary": "Mission Viejo, California • San Diego, California • North Dartmouth, Massachusetts + 3 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287364" }, { "nct_id": "NCT00953147", "title": "A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Allergic Rhinitis", "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA 80 mcg", "type": "DRUG" }, { "name": "Ciclesonide HFA 160 mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1110, "start_date": "2009-08", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 45, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 36 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00953147" }, { "nct_id": "NCT01067105", "title": "A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide HFA 160 μg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 824, "start_date": "2010-02", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-04T02:34:39.976Z", "location_count": 44, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 36 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01067105" } ] }